Clinical Trials Directory

Trials / Completed

CompletedNCT00309543

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
636 (planned)
Sponsor
Austrian Breast & Colorectal Cancer Study Group · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patients' survival time following surgery for colon carcinoma Stage II.

Conditions

Interventions

TypeNameDescription
DRUGFluorouracil
DRUGLeucovorin

Timeline

Start date
1993-11-01
First posted
2006-04-03
Last updated
2006-04-03

Locations

18 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT00309543. Inclusion in this directory is not an endorsement.

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B (NCT00309543) · Clinical Trials Directory